ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,094Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 1802

$503K Total Retail Price of All Prescriptions

Rank: 90 out of 1802

466 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 466 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 466 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,677 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 558 477 1 2
LISINOPRIL 469 425 2 3
SIMVASTATIN 433 392 3 1
AMLODIPINE BESYLATE 388 361 4 6
WARFARIN SODIUM 381 324 5 7
METOPROLOL TARTRATE 323 297 6 9
OMEPRAZOLE 262 211 7 4
TRAMADOL HCL 224 205 8 22
MIRTAZAPINE 222 210 9 38
DONEPEZIL HCL 212 200 10 26
FUROSEMIDE 210 199 11 5
PRAVASTATIN SODIUM 205 181 12 19
METOPROLOL SUCCINATE 186 142 13 13
GABAPENTIN 174 146 14 16
ATENOLOL 164 148 15 12
ALENDRONATE SODIUM 158 139 16 21
NAMENDA 157 145 17 34
HYDROCHLOROTHIAZIDE 148 139 18 8
PANTOPRAZOLE SODIUM 144 104 19 44
ATORVASTATIN CALCIUM 142 111 20 14
PAROXETINE HCL 135 110 21 60
POTASSIUM CHLORIDE 133 120 22 15
METFORMIN HCL 127 119 23 11
DOXAZOSIN MESYLATE 124 93 24 62
TAMSULOSIN HCL 124 102 24 28
DIOVAN 120 105 26 57
LOVASTATIN 112 110 27 25
TRIAMTERENE-HCTZ 112 94 27 49
LOSARTAN POTASSIUM 109 98 29 18
HYDROCODONE-ACETAMINOPHEN 107 82 S3 30 10
CARVEDILOL 98 84 31 36
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 93 31 23
PREDNISONE 98 95 31 33
BUSPIRONE HCL 96 85 34 126
SERTRALINE HCL 88 82 35 20
CLOPIDOGREL 87 86 36 48
ZOLPIDEM TARTRATE 75 59 37 27
KLOR-CON M20 69 69 38 86
GLIPIZIDE 68 59 39 51
GLYBURIDE 64 59 R 40 68
GLIMEPIRIDE 59 50 41 42
DIGOXIN 59 53 41 45
TERAZOSIN HCL 58 42 43 90
BYSTOLIC 58 52 43 120
ALLOPURINOL 58 55 43 24
CHLORTHALIDONE 55 31 46 121
PLAVIX 52 50 47 81
ADVAIR DISKUS 51 43 48 32
ISOSORBIDE MONONITRATE ER 50 50 49 66
TRIAMTERENE-HYDROCHLOROTHIAZID 50 48 49 145
IBUPROFEN 50 30 49 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.